← Back to Clinical Trials
Recruiting NCT04515342

NCT04515342 Sarcopenia, Fall and Osteoporosis in Chronic Kidney Disease

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04515342
Status Recruiting
Phase
Sponsor Herlev Hospital
Condition Sarcopenia
Study Type OBSERVATIONAL
Enrollment 140 participants
Start Date 2021-03-10
Primary Completion 2026-01-01

Trial Parameters

Condition Sarcopenia
Sponsor Herlev Hospital
Study Type OBSERVATIONAL
Phase N/A
Enrollment 140
Sex ALL
Min Age 20 Years
Max Age 120 Years
Start Date 2021-03-10
Completion 2026-01-01
Interventions
DXAMuscle strength and function assessmentBlood samples

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study is a cross-sectional study that wishes to investigate whether there is an increased incidence of sarcopenia in patients with chronic kidney disease compared to the Danish background population. A possible association between sarcopenia and fall, as well as the incidence of osteoporosis in patients with chronic kidney disease will also be described.

Eligibility Criteria

Inclusion Criteria: * Age ≥20 years * Chronic kidney disease stage 4-5 not on dialysis (nonD) (corresponding to an estimated glomerular filtration rate (eGFR) ≤30 ml/min based on Kidney Disease Improving Global Outcomes (KDIGO) definition and not on dialysis) Exclusion Criteria: * Kidney transplanted * Immobilized/hospitalized for more than 1 week within the last 6 weeks * Active treatment with growth hormone or sex hormone * Known muscle disease * The lack of ability to speak or understand Danish * The lack of ability to give an informed consent * The lack of ability to participate in a clinical study based on the assessment by the local investigator

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology